Login / Signup

Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306.

Kazuhiro TanakaRyunosuke MachidaAkira KawaiRobert NakayamaSatoshi TsukushiKunihiro AsanumaYoshihiro MatsumotoHiroaki HiragaKoji HiraokaMunenori WatanukiTsukasa YonemotoSatoshi AbeHirohisa KatagiriYoshihiro NishidaAkihito NaganoYoshiyuki SueharaHiroyuki KawashimaMasanori KawanoTakeshi MoriiHiroshi HatanoJunya ToguchidaTomotake OkumaMasanobu TakeyamaSatoshi TakenakaToshihiro AkisueTaisuke FurutaMakoto EmoriToru HirumaHidetatsu OutaniTetsuji YamamotoTomoko KataokaHaruhiko FukudaToshifumi OzakiYukihide Iwamoto
Published in: British journal of cancer (2022)
jRCTs031180003.
Keyphrases
  • phase ii
  • clinical trial
  • open label
  • phase iii
  • soft tissue
  • double blind
  • placebo controlled
  • locally advanced
  • patients undergoing
  • cardiac surgery
  • study protocol
  • acute kidney injury